Markovits, Stock & DeMarco, a law firm experienced in data breach cases, is investigating claims on behalf of victims of a data breach involving data entrusted to Puma Biotechnology, Inc. (“Puma”). If you received a notice of data breach letter or email from Puma, please contact us as soon as possible to understand your legal rights in response to the data breach.
Puma Biotechnology is a biopharmaceutical company involved in acquiring in developing pharmaceutical treatments for various diseases. Puma recently disclosed that on June 19, 2022, it became aware of some suspicious activity on its network. On June 27, 2022, an investigation revealed that an unauthorized third-party had gained access to the system and was able to access information stored on its files. Puma began notifying individuals affected by this data breach on or about May 17, 2023.
Puma confirmed that for an undisclosed or unknown period of time unauthorized third parties were able to access files and systems that were supposed to be secure. Puma has confirmed that in the course of this data breach, the personal sensitive information of certain individuals may have been compromised.
WHAT INFORMATION WAS EXPOSED IN THE DATA BREACH?
Unauthorized third parties were purportedly able to access the following information from various Puma’s network:
- Full names;
- Social Security numbers; and
- Financial account information.
WHAT SHOULD I DO IF I RECEIVED NOTIFICATION OF THE PUMA DATA BREACH?
If you would like to have a free, confidential consultation with an attorney to learn more about your rights and potential legal remedies in responding to the Puma Biotechnology, Inc. data breach, please contact Markovits, Stock & DeMarco attorney Terry Coates at (513) 651-3700, email us at [email protected], or submit a Case Evaluation request through the form below.
 See https://www.pumabiotechnology.com/ (last accessed May 18, 2023)
 See https://apps.web.maine.gov/online/aeviewer/ME/40/a193b9d8-f0ad-4f3b-952c-db1f3d322f39.shtml (last accessed May 18, 2023)